More News

18 Aug 2020 Gilead Sciences and Tango Therapeutics to Expand Strategic Oncology Collaboration
17 Aug 2020 Dragonfly Therapeutics and Bristol Myers Squibb Announce Exclusive Global License for Dragonfly’s IL-12 Investigational Immunotherapy Program
17 Aug 2020 Abeona Therapeutics and Taysha Gene Therapies Enter into Licensing and Inventory Purchase Agreements for ABO-202, a Clinical Stage, Novel, One-time Gene Therapy for CLN1 Disease
17 Aug 2020 Sanofi to acquire Principia Biopharma
12 Aug 2020 GeneCentric Therapeutics Enters into Research Collaboration with Janssen on Genomic Drug Response Biomarkers for Non-Muscle Invasive Bladder Cancer
11 Aug 2020 Bayer to Acquire UK-Based Biotech KaNDy Therapeutics Ltd.
11 Aug 2020 Ligand to Acquire Pfenex Inc.
10 Aug 2020 Verastem Oncology Signs Definitive Agreement to Sell COPIKTRA® (duvelisib) Rights to Secura Bio to Focus on Development of VS-6766 and Defactinib in KRAS Mutant Solid Tumors
06 Aug 2020 Biogen and Denali to Collaborate on LRRK2 Program for Parkinson’s Disease and Certain TV Platform-Enabled Programs for Neurodegenerative Diseases
06 Aug 2020 T-knife Completes €66 Million Series A Financing to Develop Next-Generation T-Cell Therapies
06 Aug 2020 GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases
06 Aug 2020 Taysha Gene Therapies Announces Oversubscribed $95 Million Series B Financing to Bolster Initial Clinical Studies in GM2 Gangliosidosis and Advance Pipeline of Gene Therapies for Monogenic CNS Disease in Both Rare and Large Patient Populations
06 Aug 2020 Teva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market
04 Aug 2020 Redx signs out licensing agreement with AstraZeneca
04 Aug 2020 LUMICKS enters collaboration with Glycostem to enhance NK cell-mediated immunotherapy
30 Jul 2020 Sangamo Announces Global Collaboration With Novartis to Develop Genomic Medicines for Autism and Other Neurodevelopmental Disorders
30 Jul 2020 Spring Bank Pharmaceuticals and F-star Therapeutics Agree to Combine to Pursue Mission of Creating Next Generation Immunotherapies
29 Jul 2020 Lilly's P-tau217 Blood Test Shows High Accuracy in Diagnosis of Alzheimer's Disease in Data Published in JAMA
28 Jul 2020 Terns Pharmaceuticals and Hansoh Pharma Announce Collaboration and License Agreement for TRN-000632 in Greater China
27 Jul 2020 Lynk Pharmaceuticals enters exclusive licensing agreements with Kobe University and with RIKEN Research Institute to develop RAS inhibitors with a novel MOA
24 Jul 2020 Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 and Cancer Therapeutics
24 Jul 2020 Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant
23 Jul 2020 G1 Therapeutics Announces License Agreement for Lerociclib
22 Jul 2020 Qualigen Therapeutics Signs Exclusive License Agreement with the University of Louisville for RAS Interaction Inhibitor Drug Candidates
21 Jul 2020 UNION therapeutics announces acquisition of PDE4i compound class from LEO Pharma with oral lead candidate (orismilast) in Phase 2

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up